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nosis and timely institution of therapy and initiation of
infection control measures. The enhanced sensitivity of PCR
may obviate the need for additional testing.14th International Congress on Infectious Diseases (ICID) Abs
75.005
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Background: Homeless youth living on the streets of large
cities and engaging in unprotected sex are at risk of infec-
tions with C. trachomatis [CT], N. gonorrhoeae [GC], T.
vaginalis [TV], and human papillomavirus [HPV]. The APTIMA
transcription mediated ampliﬁcation [TMA] assays are sen-
sitive and speciﬁc for detecting genital infections using
various sample types.
Methods: In Group A, 296 women signed informed con-
sent for collection of 2 cervical swabs [CS] and a liquid-based
Pap [L-Pap] [SurePath] sample. In Group 2, 289 women self-
collected a vaginal swab [VS]. CS and VS were tested for CT
and GC using APTIMA Combo 2 [AC2] conﬁrmed with ACT and
AGC assays. VS were also tested for TV using analyte speciﬁc
reagents [ASR] in an APTIMA protocol and conﬁrmed using a
research TMA directed against alternate targets. The L-Pap
sample and CS were tested for 14 high-risk [HR] HPV geno-
types using the APTIMA HPV [AHPV] mRNA test [Gen-Probe]
and conﬁrmed using HC2 [Qiagen] or HPV Linear Array [LA]
[Roche].
Results: Prevalences were as follows: CT 12% [70/585];
GC 2.6% [15/585]; CT and GC 1.5% [9/585]; TV 13.5%
[39/289]; HR-HPV 35.5% [105/296] and HR-HPV and CT were
present in 7.1% [21/296]. CT, GC and HR-HPV were present
in 2 patients. The most common HPV genotypes in descend-
ing order were 16, 51, 52, 56, 18, 31, 39, 58, 33, 45, 35, 59,
68, 66. Many samples contained more than 1 genotype, and
the greatest number in a patient was 6.
Conclusion: Using APTIMA assays to screen genital infec-
tions in this younger, largely asymptomatic population
demonstrated a high burden of infection. The use of multiple
assays enabled conﬁrmation of results and early treatment.
Infections with several organisms and HPV genotypes indi-
cate a public health concern for the sexual health of these
homeless individuals.
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Background: Despite the rising morbidity and mortality
f Clostridium difﬁcile infection (CDI), a rapid and reliable
est to conﬁrm the diagnosis remains elusive. The cell cul-
ure cytotoxin assay (CCCA), considered the gold standard, is
omplex and time consuming. Commonly used EIA methods
or detecting toxins A & B have sensitivities of only 50-90%,
eading to confusion regarding the interpretation of nega-
ive tests. The Cepheid Xpert Clostridium difﬁcile PCR test
as recently FDA approved and may improve sensitivity and
peciﬁcity with faster turnaround time. We sought to evalu-
te the clinical utility of this new PCR test compared to the
tandard Meridian Premier EIA toxin A/B test.
Methods: Consecutive stool samples submitted for detec-
ion of C. difﬁcile toxin at our 808 bed medical center were
nalyzed with both Meridian Premier EIA and Cepheid’s Xpert
CR assay. The ﬁrst submitted stool sample for each adult
ospitalized patient was included. True CDI was deﬁned as
positive test by either the PCR or EIA methods, along with
he presence of clinical symptoms of infection (ie, diarrhea,
ever, abdominal pain, elevated WBC count). If the test were
iscordant, CCCA was performed at a reference laboratory.
Results: 161 cases met inclusion criteria; 30 cases (18.6%)
ere diagnosed with CDI. The sensitivity, speciﬁcity, positive
negative predictive values of the PCR test (97%, 100%,
00%, and 99%) were superior to the EIA test (43%, 97%, 76%,
nd 88%). Four cases were EIA+/PCR-; only one of these had
linical symptoms consistent with CDI. EIA-/PCR+ was noted
n 16 cases; all clinically had CDI. Of 16 discordant samples
hat underwent CCCA, only 1 (6%) tested positive.
Conclusion: PCR signiﬁcantly improved the diagnosis of
atients with suspected CDI; 16 additional patients with
linically evident disease were detected by PCR that were
issed by EIA. CCCA was insensitive, with no correlation
o other testing methods or clinical disease. PCR testing
ppears superior to EIA and allows for rapid, reliable diag-oi:10.1016/j.ijid.2010.02.406
